http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106749672-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24234 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8251 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6803 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate | 2016-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106749672-B |
| titleOfInvention | Hepatitis C virus fusion antigen protein and application thereof |
| abstract | The invention discloses a recombinant hepatitis C virus fusion antigen protein, which is prepared by constructing full-length and truncated mutant expression vectors of hepatitis C virus proteins Core, E1 and E2 and fusion antigen HCV fused with strong immunogenicity regions of the three virus proteins les Expression vectors, and expression of the respective proteins by tobacco hosts, found fusion antigen proteins HCV, compared to full-length and truncated mutant proteins thereof of Core, E1 and E2 les The serum reactivity and virus inhibition capability of a hepatitis C virus infected person are obviously enhanced in the aspect of inducing a neutralizing antibody, and the neutralizing antibody shows a synergistic interaction effect, so that the hepatitis C virus fusion antigen has a good prospect of being used as a hepatitis C virus vaccine or diagnostic reagent, and can provide a new solution for the preparation of the hepatitis C virus vaccine or diagnostic reagent. |
| priorityDate | 2016-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 233.